Key points
- The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.
- These recommendations become official ÐÇ¿ÕÓéÀÖ¹ÙÍø policy once adopted by ÐÇ¿ÕÓéÀÖ¹ÙÍø's Director.
- Learn about current and historical ACIP recommendations for Ebola vaccine.
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the ÐÇ¿ÕÓéÀÖ¹ÙÍø regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the ÐÇ¿ÕÓéÀÖ¹ÙÍø Director and, if adopted, are published as official ÐÇ¿ÕÓéÀÖ¹ÙÍø/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Ebola Vaccine Recommendation
MMWR, February 25, 2022, Vol 71(8);290–292
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021
Print version
MMWR, January 8, 2021, Vol 70(1);1–12
Use of Ebola Vaccine in the United States
Print version